Membrane-type matrix metalloproteinases-1 and -3 (MT1-and MT3-MMPs) are expressed by activated smooth muscle cells (SMCs) both in vitro and in vivo (19) . To define their functions in SMCs, we transduced MT1-and MT3-MMP cDNAs into baboon SMCs by using adenoviral vectors. Overexpression of MT1-MMP increased the conversion of proMMP-2 to the intermediate and active forms. In contrast, in MT3-MMP-overexpressing cells, MMP-2 was activated partially. Immunoblot analyses revealed that MT1-MMP protein was present in the SMCs and accumulated in the presence of the synthetic MMP inhibitor, BB94, or tissue inhibitor of metalloproteinase-2 (TIMP-2). However, MT3-MMP protein was detectable only when BB94, but not TIMP-2, was present. Zymographic analyses showed that MT3-MMP had much stronger casein-and gelatin-degrading activities than did MT1-MMP. Furthermore, when MT3-MMP and MT1-MMP were coexpressed, MT1-MMP degradation was enhanced; this result supports the possibility that MT3-MMP can degrade MT1-MMP. SMCs overexpressing either MT1-or MT3-MMP exhibited altered morphology, without changing their proliferation. This alteration was prevented by BB94 addition. The cells, which underwent this change, showed reduced adhesion to both collagen and fibronectin and increased migration in a Boyden chamber. The present study demonstrates that MT1-and MT3-MMPs have different enzymatic activities but may nevertheless affect SMC function in the same way.
MMP-2 (gelatinase A) degrades basement membrane type IV and denatured interstitial collagens and is thought to be one of the most important MMPs in tissue remodeling or cell migration (4) (5) (6) . Membrane-type (MT) MMPs are a subgroup of MMPs, which have a transmembrane sequence in their carboxy terminus and are believed to be specific activators of proMMP-2 (for review, see 7, 8) . At the cell surface, MT1-MMP binds TIMP-2 to the catalytic center, and this complex, in turn, acts as a receptor for MMP-2. Through the carboxyl half of TIMP-2, which has an affinity to the hemopexin-like domain of MMP-2, proMMP-2 is bound to the TIMP/MT1-MMP complex and is then processed into an unstable intermediate form by cleavage by another MT1-MMP between Asn 37 -Leu 38 . Finally, the active form of MMP-2 is generated by autocatalytic cleavage of an Asn 80 -Tyr 81 bond (9) (10) (11) (12) . Thus, TIMP-2 is essential for the initial activation step, but an excess amount of TIMP-2 can inhibit it by occupying both the reactive site of MT1-MMP and the hemopexin-like domain of MMP-2. This complex mechanism effectively localizes the MMP-2 activity on the cell surface or in the peri-cellular space.
Much interest has been focused on the role of MMPs in vascular diseases such as atherosclerosis, restenosis, and aortic aneurysms (for review, see [13] [14] [15] . Vascular smooth muscle cells (SMCs), like invasive cancer cells, express MMPs and TIMPs under pathological conditions (16, 17) . We have reported that cultured rat SMCs express MT1-, MT2-, and MT3-MMPs simultaneously (18) . The expression of MT1-and MT3-MMPs is stimulated in vitro by factors, such as PDGF or IL-1, and in vivo by balloon injury (19) . However, the specific functions of these molecules have not been defined. MT3-MMP in particular is not well characterized, although it is known to activate proMMP-2 and directly degrade some matrix molecules in vitro (18, 20) . To define the role of MT1-and MT3-MMPs, we have expressed these two MT-MMP cDNAs in cultured baboon SMCs. Here, we report that they differ in the activation of MMP-2 and the inhibition by both TIMP-2 and a synthetic inhibitor but are similar in their impact on SMC morphology and migration.
MATERIALS AND METHODS

Materials
A hydroxamic inhibitor of MMPs, BB94 (Batimastat), was provided by British Biotechnology (Oxford, UK). Bovine TIMP-1, human TIMP-2 and MMP-2, and anti-human MT3-MMP antibody were purchased from Chemicon International (Temecula, CA). Recombinant PDGF-BB was kindly supplied by Zymogenetics (Seattle, WA). Anti-MT1-MMP antiserum raised against a synthetic MT1-MMP sequence in the hemopexin-like domain is a kind gift from Immunex (Seattle, WA). Anti-TIMP-2 monoclonal antibody was prepared as reported (11) . Pepsindigested type I collagen (Vitrogen) was purchased from Celtrix (Richmond, VA). A reconstituted basement membrane matrix, Matrigel, was purchased from Collaborative Research (Bedford, MA).
Cells
Baboon aortic SMCs were prepared as previously described (17) . An MMP-2-negative gastric carcinoma cell line, MKN-45, was obtained from Japanese Cancer Resources Bank (Tokyo) (21) .
Adenovirus vector development and infection of the cells
The cDNA for rat MT1-MMP (18) was amplified by PCR, sequenced, and then inserted into the multiple cloning site of the adenoviral shuttle vector in both sense and antisense orientations (AdMT1S and AdMT1AS, respectively). Similarly, the human MT3-MMP cDNA (18) was inserted into the HindIII site of the adenoviral vector in a sense orientation (AdMT3). The replication-defective adenoviral vectors expressing MT-MMP cDNA were prepared in the University of Washington adenoviral vector core (22) .
SMCs (5 × 10
4 ) were plated in 12-well plates, 24 h before infection. Adenovirus was incubated with the cells for 18-24 h in 10% serum containing DME medium. To prepare the media conditioned by SMCs, cells were switched to serum-free culture and media was recovered 12-72 h after incubation. Total cell lysates were prepared by directly adding 1 ml of SDS sample buffer. When it is necessary, the protein in the conditioned media (CM) was precipitated by treating it with trichloroacetate at 10% of final concentration on ice for 1 h to concentrate protein. After centrifugation, samples were washed twice with ice-cold acetone, air-dried, and dissolved in SDS sample buffer.
Zymographic analyses
Zymography was carried out on 10% polyacrylamide gels containing 1 mg/ml of gelatin or casein, as described previously (18) . CM (5-10 µl) or 20 µl of total cell lysates were applied to the gel. In some cases, zymograms were densitometrically scanned and gelatinlytic activities of pro-, intermediate, and active forms were individually quantitated by ImageQuant software (Molecular Dynamics, Sunnyvale, CA). The activation ratio was estimated by dividing the activities of intermediate and active forms by a total of three bands.
Immunoblotting analyses
Total cell lysates (40 µl) treated with or without β-mercapto-ethanol were separated on polyacrylamide gels (10% for MT-MMPs and 12.5% for TIMP-2) and electrophoretically transferred onto nitrocellulose membranes. The membranes were reacted with an antibody to MT1-MMP or MT3-MMP and visualized by the alkaline phosphatase method as described previously (18) .
Activation of purified MMP-2 in vitro by membrane fraction
Baboon SMCs (1 × 10 6 ) were plated and infected with a series of adenoviruses at a multiplicity of infection (MOI) of 3 × 10 2 . Crude plasma membrane fraction was prepared from the cells 72 h after the infection, as reported (34) , with minor modifications. In brief, cells from serum-free culture with BB94 were washed three times with cold phosphate-buffered saline to remove the inhibitor and endogenous soluble MMPs, scraped in 10 mM HEPES (pH 7.5) containing 0.25 M sucrose, and homogenized. Samples were transferred to Eppendorf tubes and centrifuged at ,000 rpm for 5 min to remove nuclei. The crude membrane fraction was recovered by centrifuging the supernatants again at 15,000 rpm for 30 min as pellets. The fraction was kept frozen at -80°C until use. The fraction was dissolved in 50 µl of 50 mM Tris HCl (pH 7.4) containing 150 mM NaCl, 1mM MgCl 2 , 0.1 mM CaCl 2 , and 15 mM CHAPS. Purified MMP-2 (10 ng) was incubated in 25 mM HEPES (pH 7.5) containing 1mM of CaCl 2 with 1 µl of the membrane fractions in the presence or absence of MMP inhibitors for 5 h at 37°C. The reaction was stopped by adding SDS sample buffer and then applied to gelatin zymography to examine the MMP-2 activation status.
Cell adhesion assay
Cells infected with adenoviral vectors were cultured for 72 h in the presence of 10% FCS. Cells were trypsinized and neutralized with soybean trypsin inhbitor (Sigma, St. Louis, MO). Cells were placed in 96-well plates (1.5 × 10 4 cells/well) coated with 0.1 mg/ml of unpolymerized type I collagen, fibronectin (Sigma), or Matrigel. After 1 h of incubation, the cells were washed with phosphate-buffered saline to remove the unattached cells, fixed with formalin, stained with toluidine blue dye, and photometrically quantified. Results were shown as the mean ±SD of four experiments. Statistical significance was set at P≤0.05 by standard t test.
Cell migration assay
Migration of SMCs was analyzed by the modified Boyden's chamber method using 48-well microchemotaxis chambers (Neuro Probe, Gaithersburg, MD) (23) . Polycarbonate filters with 10.0-µm pores (Nucleopore, Pleasanton, CA) were coated with 100 µg/ml of unpolymerized type-I collagen (Vitrogen) overnight and then allowed to dry. SMCs were trypsinized, neutralized by 10% FCS addition, and resuspended in serum-free DMEM at 4 × 10 5 cells/ml. DMEM (26-28 µl) containing 10 ng/ml of PDGF-BB as a chemoattractant was added to the lower chambers. The cell suspension (50 µl) was placed in the upper chamber. After 6 h of incubation at 37°C and 5% CO 2 , the cells on the upper side of the filters were scraped off. The filters were fixed with methanol, and the cells that had migrated to the lower side of the filters were stained with Diff-Quick staining (Baxter, Deerfield, IL) and counted under a microscope. Migration activity was expressed as the number of migrated cells per grid (0.88 mm 2 ) (mean ±SD of four experiments). Statistical significance was set at P≤0.05 by standard t test.
RESULTS
Expression of MT-MMPs
Rat MT1-MMP cDNA was inserted into an adenoviral shuttle vector in both the sense and the antisense orientations and replication-defective adenovirus vectors, AdMT1S and AdMT1AS, were generated. Similarly, an adenovector, which expressed human MT3-MMP cDNA in the sense orientation (AdMT3), was also developed. These viruses were used to infect baboon SMCs at a MOI of 10, 10 2 , and 10 3 . When total cell lysates were analyzed by immunoblotting, endogenous MT1-MMP protein (60 kDa) of control cells was slightly detectable. AdMT1 infection increased the level in a dose-dependent manner. This increase in MT1-MMP protein matched the increase in mRNA expression (2.1-fold at a MOI of 3 × 10 2 ) determined by RT-PCR. Cells stimulated with TPA, a known inducer of the gene (19), exhibited a slightly lower level (1.6-fold) of MT1-MMP mRNA (data not shown). AdM1AS had no effect on the basal protein expression of MT1-or MT3-MMP (Fig. 1A) . We used AdMT1AS-infected cells as a negative control for both AdMT1 and AdMT3 overexpressing cells. AdMT3 infection did not change the endogenous expression of MT1-MMP protein. The MT1-MMP protein accumulation increased when BB94 was added to the culture (11). In our immunoblots, MT1-MMP was detected as a doublet of major 60 kDa and faint 65 kDa bands, under the nonreducing condition (Fig. 1A) . These bands correspond to the calculated molecular weights of pro-and intracellular forms, respectively. We were unable to detect the 57-kDa active form (cleaved at the furin recognition site) or any other processed form of MT1-MMP under the conditions tested. A synthetic furin inhibitor (Dec-RVKR-Cmk) showed no effect on the protein expression and MMP-2 activation at concentrations up to 50 µM (data not shown). These results support the conclusion that MT1-MMP can be active with a propeptide sequence in SMCs, as reported elsewhere (24) (25) (26) .
Protein expression of MT3-MMP (65 kDa) was not detected by immunoblot analyses in control or in AdM3-infected cells, even at a MOI of 10 3 . However, when BB94 was added to the culture, three bands ranging from 60 to 70 kDa were detected under both nonreducing (Fig. 1B ) and reducing conditions (data not shown). This result suggests far more rapid degradation of MT3-MMP than MT1-MMP (Fig. 2B) . A 56-kDa band representing MT3-MMP, which is cleaved by furin, was not detected in any conditions tested, and the furin inhibitor also did not affect the MMP-2 activating activity of MT3-MMP (data not shown). MT1-and MT3-MMP in AdMT1-and AdMT3-infected SMCs were not detected in the CM (data not shown).
ProMMP-2 activation by MT1-MMP and MT3-MMP
To analyze the MMP-2-activating activity of MT-MMPs expressed by the adenovirus system, serum-free CM was recovered 24, 48, and 72 h after the culture was analyzed by gelatin zymography. In SMCs infected over 24 h with AdMT1 at a MOI of 10 2 , endogenous 66-kDa proMMP-2 was detected as well as 57-kDa active and 59-kDa intermediate forms ( Fig. 2A) . The conversion of proMMP-2 to the lower weight intermediate form was more pronounced at an MOI of 10 3 . The activation of MMP-2 continued at 48 h (data not shown) and was most pronounced at 72 h ( Fig. 2A, second row) . The activation was inhibited by adding the synthetic MMP inhibitor, BB94 (10 µM). In contrast, AdMT1AS expression did not affect the pattern of activation at the highest MOI tested (3 × 10 3 , data not shown). AdMT3 infection also promoted MMP-2 activation, although the pattern was different from that of AdMT1. The 59-kDa band on gelatin zymograms was more intense than the 57-kDa band. When the zymograms were densitometrically scanned, the ratio of 64-kDa to 59-kDa to 57-kDa bands was 1.0:2.1:3.0 in the conditioned medium of AdMT1-infected cells (MOI 10 3 , at 72 h) and was 1.0:4.3:2.2 in the conditioned medium of AdMT3-infected cells (MOI 10 3 , at 72 h). Therefore, in this regard, MT1-MMP was a more efficient MMP-2-activating enzyme than was MT3-MMP. In addition, BB94 was less effective in inhibiting the activation of MMP-2 catalyzed by MT3-MMP. When rat SMCs were used to overexpress MT-MMPs with the same adenoviral system, similar results were obtained (T.S., unpublished observations).
To measure the changes in cell-associated proteinases, total cell lysates were also analyzed by gelatin zymography. The pattern was similar to that of secreted proteinases. However, intense and diffuse 60-kDa activity, which almost overlapped with activated MMP-2, was detected in AdM3-infected SMCs with BB94 ( Fig. 2A, bottom) . The activity could be blocked by incubating the gel with BB94 after electrophoresis (Fig. 2B ). MT3-MMP activity was also detected by zymography with casein substrate, which was not degraded by MMP-2, whereas lysate from AdMT1S-infected cells did not show any caseinolytic activity (Fig. 2C ). These results demonstrate that MT3-MMP can degrade gelatin directly.
Changes of TIMP-2 expression were analyzed because it is well known that TIMP-2 is important in regulating MMP-2 activation by MT1-MMP (9-11). In uninfected SMCs, TIMP-2 was detected abundantly in CM and slightly in total cell lysates by immunoblotting, and its level was not affected by control AdMT1AS infection (Fig. 2D) . However, in AdMT1S-infected cells (at a MOI of 3 × 10 2 ), CM TIMP-2 was dramatically decreased and the cell-asociated TIMP-2 was increased. It is important that these changes were reversed by BB94 addition, whereas BB94 did not show any effect in the control cells. Similar results were observed in MT3-MMP overexpressing cells, although the changes were somewhat weaker. These results support the previous findings that the binding of TIMP-2 to cell surface MT1-MMP is crucial for the efficient activation of proMMP-2 and also suggest that the same is true for the activation by MT3-MMP.
Degradation of MT-MMPs in a MMP-2 negative cell line
To rule out the possibility that BB94-sensitive degradation of MT-MMPs might be catalyzed by the activated MMP-2, an MMP-2 negative cell line was used as a host cell. A gastric cancer cell line, MKN-45, has been shown to be MMP-2 negative by both gelatin zymography (21) and RT-PCR (N. Koshikawa, personal communication). Expression of MT1-MMP in control cells was weakly detected at 64 kDa by immunoblotting under reducing conditions. AdMT1 infection induced the expression of the 64-kDa and the 67-kDa forms (Fig. 3, right panel) . The expression level was further increased upon the addition of BB94 to the culture. MT3-MMP was undetectable with or without the BB94 addition in the control cells. MT3-MMP (65 kDa) was detected after the AdMT3 infection only in the presence of BB94. When the lysates were analyzed by gelatin zymography, the proteolytic activity of MT3-MMP was detectable at about 60 kDa, whereas that of MT1-MMP was undetectable (Fig. 3, left panel) . Thus, the pattern of MT1-and MT3-MMP protein accumulation in the presence and absence of BB94 was similar in MMP-2 positive and negative cells. These results support the conclusion that MT-MMP expression might be regulated by autodegradation and that MT3-MMP degrades gelatin but MT1-MMP does not.
Inhibition of MMP-2-activating activity and degradation of MT-MMP by both synthetic and natural inhibitors
The activity of MMPs is controlled in part by the simultaneous secretion of specific inhibitors. We therefore compared the inhibitory effects of BB94 and the natural inhibitor, TIMP-2, on the MMP-2-activating and -degrading activities of MT-MMPs. AdMT1 and AdMT3 were infected at a MOI of 3 × 10 2 , and increasing amounts of BB94 or purified TIMP-2 protein were added into the serum-free culture. CM and total cell lysates were analyzed 48 h after the culture by gelatin zymography and immunoblot, respectively. Results were quantitated and activation efficiency was estimated as described in Materials and Methods. As shown in Figures 4A and 4C , MMP-2 activation in AdMT1-infected cells (at a MOI of 3 × 10 2 , 85% activation without inhibitors) was efficiently inhibited by BB94 (10% activation at 10.0 µM) and TIMP-2 (10% activation at 200 nM). However, the activation of MMP-2 by MT3-MMP (at a MOI of 3 × 10 2 ) was partially inhibited by all concentrations of BB94 and TIMP-2. In addition, TIMP-1 at 100 nM showed no effect on MMP-2 activation in both MT1-MMP-and MT3-MMP-transduced cells (data not shown).
The degradation of MT1-MMP was efficiently inhibited by BB94 and reached a maximum at 5 µM (Figs. 4B, D) . Similarly, the antidegrading effect of TIMP-2 reached a maximum at 100 nM. BB94 had a similar effect on MT3-MMP. TIMP-2, even at 200 nM, had a weak effect on inhibiting the degradation of MT3-MMP. These results clearly show that these two MT-MMPs differentially respond to MMP inhibitors and that MT3-MMP is resistant to the well-known synthetic and natural inhibitors. It is notable that the proteolytic activity of MT3-MMP examined under denaturing conditions was easily inhibited by BB94 even at 1 µM (Fig. 1B) . Therefore, the tertiary structure of the protein could be important for the resistance to autodegradation. To confirm this hypothesis in a cell-free system, plasma membrane fractions were prepared from MT-MMP overexpressing cells and were incubated with purified MMP-2. Zymographic analysis revealed that MMP-2 applied to the reaction consisted of pro-and active forms, whereas the intermediate was undetectable (Fig. 5, inset) . Incubation of the MMP-2 with membrane fractions prepared from both control uninfected or AdMT1AS-infected SMCs did not affect MMP-2 activation (data not shown). However, incubation of MMP-2 with the membrane fraction from MT1-MMP overexpressing cells increased the conversion of pro-MMP-2 to the active form through the intermediate form (Fig. 5) , and BB94 inhibited this activation, at concentrations as low as 50 nM (data not shown). The inhibition by TIMP-2 showed similar dose dependency to the cultured condition. The fraction from MT3-MMP overexpressing cells also activated MMP-2, and it was also efficiently inhibited by BB94 (Fig. 5, lower panel) . However, the activation by MT3-MMP showed resistance to TIMP-2 even at 200 nM.
Cell surface MT1-MMP degradation by MT3-MMP
To investigate possible interactions between MT1-and MT3-MMP, we coinfected SMCs with MT1-MMP and MT3-MMP. Increasing amount of AdMT3 was coinfected with AdMT1 at a MOI of 1 × 10 2 . The protein expression of MT1-MMP was decreased in a dose-dependent manner (Fig. 6A) . Especially, the 64-kDa mature form was more sensitive than the 67-kDa intracellular form, and the proportion of 67-kDa form to 64-kDa one was shifted from 1:5 to 1:2 at a MOI of 1 × 10 3 . This change was inhibited by BB94 addition (5 µM) (data not shown). These data suggest that MT1-MMP could be degraded by MT3-MMP, presumably on the cell surface.
When AdMT1AS was coinfected with AdMT1, a similar inhibitory effect on MT1-MMP protein expression was observed (Fig. 6A) . However, in this case, both 67-kDa intracellular and 64-kDa mature forms of MT1-MMP were decreased with similar proportion and were not changed by BB94 addition (data not shown). These data suggest that AdMT1AS could suppress the increased expression of MT1-MMP mRNA, although it had no effect on MT1-MMP expression in the control cells (Fig. 1A and Fig. 2A ). This negative effect of AdMT1AS was reflected in the reduced MMP-2 activation (Fig. 6A) . However, we did not see a similar effect in the MT3-MMP coinfection study because of the MMP-2-activating activity of MT3-MMP. In addition, no synergistic effect between MT1-and MT3-MMPs on MMP-2 activation was detectable. To confirm the specificity of this coinfection study, AdMT1AS and AdMT3 were coinfected with a similar adenovector-encoding β-galactosidase (Adβ-gal). As shown in Figure 6B , neither AdMT1AS nor AdMT3 inhibited the expression of β-galactosidase.
Morphological alteration of SMC transduced MT-MMPs and the effect of MMP inhibitors
Significant morphological changes were observed in both MT1-and MT3-MMP overexpressing cells. As shown in Figure 7 , SMCs that were infected with AdMT1 or AdMT3 at a MOI of 3 × 10 2 became rounded and some cells detached from the culture dishes (MT1 and MT3). Infection with AdMT1AS produced no effect (Fig. 7C) . The effects were partially detectable at a MOI of 100 and most pronounced at 1 × 10 3 (data not shown). These changes were prevented by the addition of BB94 (1 µM) (MT1+BB94) or partly by TIMP-2 (200 nM) (data not shown). These results suggest that the proteolytic activity of MT-MMPs could be involved in the alteration of phenotype. No significant difference in their growth profile was observed among AdMT1S, AdMT1AS, and AdMT3 infection (data not shown).
Reduced adhesion and increased migration of SMC overexpressing MT-MMPs
The altered morphology of SMC overexpressing MT-MMPs prompted us to analyze their adherence and migration. First, cell adhesion to extracellular matrices was analyzed. Figure 8 shows representative results from three independent experiments. MT1-and MT3-MMP overexpressing SMCs showed reduced adhesion to type I collagen and fibronectin, compared with control AdMT1AS (35 and 30% reduction, respectively). Adβ-gal-transduced cells showed a similar level of the activity as that of AdMT1AS (data not shown). Cell migration activity was measured in a modified Boyden chamber. MT1-and MT3-MMP-transduced cells showed increased migration through the filter compared with control Adβ-gal-transduced or AdMT1AS (data not shown) cells (Figs. 9A, B) . BB94 inhibited PDGF-induced migration of the MT1-and MT3-MM-expressing cells but not the control cells (Fig. 9C) .
DISCUSSION
In previous studies, we reported that activated vascular SMCs expressed MT1-and MT3-MMP both in vitro and in vivo (18, 19) . To elucidate the roles of MT1-and MT3-MMPs in blood vessels, we transduced cDNAs for MT1-and MT3-MMPs into cultured baboon SMCs using adenoviral vectors. Overexpression of MT1-MMP promoted MMP-2 activation, whereas MT3-MMP overexpression only partially activated MMP-2. These two enzymes responded differently to both natural and synthetic inhibitors but caused similar effects on SMC morphology, adhesion, and migration.
Both MT3-MMP and MT1-MMP degradation is prevented by hydroxamic inhibitors (11, 18, 27) . MMP-2 activated by MT1-MMP is not involved in MT-MMP degradation because a peptide inhibitor specific for MMP-2 does not affect it (28) and degradation is observed in cells lacking MMP-2 (29) . In the MT3-MMP overexpressing cells, MT3-MMP protein was undetectable without BB94, although the MMP-2-activating activity was easily detected by zymography. This result suggests that MT3-MMP is degraded more rapidly than MT1-MMP. Most importantly, the natural inhibitor, TIMP-2, at physiological concentrations, failed to inhibit the degradation. Consequently, MT3-MMP would likely have a very short half-life and act momentarily on the cell surface. Although all of the evidence presented here strongly suggests that the BB-94-sensitive degradation of MT-MMPs could be autodegradation, we refrain from using the term in this text. We are unable to rule out the possibility that other BB94-sensitive enzyme(s) might be responsible for the degradation.
The binding of TIMP-2 to MT1-MMP is a prerequisite for the formation of a receptor-like complex for proMMP-2. The membrane-bound proMMP-2 is cleaved by another MT1-MMP and converted to the intermediate form The intermolecular autocatalysis between the membranebound intermediate forms generates the active form. An excess amount of TIMP-2 will occupy most of the reactive sites of MT1-MMP and MMP-2 and inhibit the activation (9-11) ; how MT3-MMP activates MMP-2 is unknown. As shown in Figure 1 , conversion of the intermediate to the active forms of MMP-2 was less efficient in MT3-MMP overexpressing cells compared with the conversion from the proform to the intermediate form. This incomplete conversion by MT3-MMP might reflect the instability of MT3-MMP/TIMP-2 complex. Therefore, MMP-2 can be released from cell surface before its complete activation. In fact, as shown in Figure 2D , TIMP-2 accumulated in the cell lysates and was decreased in CM of MT1-MMP overexpressing cells. This change was observed in MT3-MMP overexpressing cells to a lesser extent. Therefore, it is possible that the affinity of TIMP-2 to MT3-MMP could be weaker than that to MT1-MMP. In addition, the limited inhibitory effect of TIMP-2 on the MT3-MMP degradation (see Figs. 4B, D) also supports the possibility that the affinity of TIMP-2 for the reactive site of MT3-MMP might not be strong enough to form a stable enzyme/inhibitor complex, which also acts as receptor for proMMP-2. The resistance of MT3-MMP to inhibitors could be due to its tertiary structure on the cell surface. Inhibitors might be inaccessible to the reactive site of the enzyme. In fact, the proteinase activity of MT3-MMP detected by zymography in denaturing conditions was completely inhibited by adding BB94 to the reaction mixture at 1 µM (Fig. 1B) . Shimada et al. reported that the enzymatic activity of MT3-MMP, which is expressed by E. coli and is lacking transmembrane sequence, is inhibited in vitro by TIMP-2 in a 1:1 stoichiometry (20) . However, the resistance of MT3-MMP to TIMP-2 was reproduced in a cell-free MMP-2 activation assay using membrane fractions (Fig. 5) . A more detailed study is needed to clarify the structure-function relationship between MT-MMPs and inhibitors.
MT1-and MT3-MMPs are detected in SMCs in the neointima formed 14 d after the balloon injury of rat carotid arteries (19) . BB94 effectively inhibits the formation of intimal thickening only in the early phase following arterial injury in rats (30) . Therefore, the activity of MT3-MMP, which is resistant to MMP inhibitors, might play important roles in the formation of intimal thickening in the late phase. MT3-MMP could act as a negative regulator of MT1-MMP. MT3-MMP degraded MT1-MMP when MT3-MMP was coexpressed with MT1-MMP (see Fig.  6 ). This degradation of MT1-MMP by MT3-MMP might not be physiological, because MT1-MMP expression is often predominant over MT3-MMP (11, 19, 31) . However, it is still possible that MT3-MMP could suppress MT1-MMP under some conditions, because MT3-MMP is usually coexpressed with MT1-MMP in cells, such as SMCs and gliomas, or in tissues such as injured blood vessels and brain (19, 32) . The coinfection of AdMT1AS with AdMT1S also showed a decrease in MT1-MMP expression, although AdMT1AS does not reduce the basal expression of MT1-MMP (Fig. 6 ).
Although we do not completely understand the mechanisms involved in phenotypic changes in MT-MMP overexpressing cells, they could depend directly on the MT-MMPs and not the activation of MMP-2. Relatively higher doses of BB94 were required to inhibit the phenomenon, supporting a direct role of MT-MMPs. BB94 is known to inhibit the MMP-2 activity in the nanomolar range in vitro (30) . In addition, although MT3-MMP inefficiently activates MMP-2, overexpression of this enzyme produced similar changes as did MT1-MMP overexpression. When the CM recovered from MT1-and MT3-MMP overexpressing SMCs was added to the uninfected cells, no morphological change was observed (data not shown). Therefore, it is not likely that activated MMP-2 played a primary role in the change in phenotype.
It is evident that MMPs, particularly MMP-2, are involved in altering cell behavior. For example, activated MMP-2 can cleave laminin-5 at specific sites of γ-chain and the cleaved laminin-5 acquires a strong cell migratory activity and produced morphological changes in mammary epithelial cells (33, 34) . Fibronectin fragments (35) or degraded collagen (36) modify cell migration activity. MT-MMPs could trigger such complex mechanisms directly or through MMP-2 activation. However, Koyama et al. reported that activation of β1 integrin by an activating antibody can promote enhanced adhesion and reduced migration of SMCs (37) . It is also possible that MT-MMPs might be responsible for the modulation of the activation status of integrins. As recently reported by Hotary et al., in cells that were transfected with three MT-MMP cDNAs, only MT3-MMP expressing cells did not show invasive activity into collagen matrices (38) . Not only could MT-MMPs, especially MT3-MMP, act as MMP-2-activating enzymes, but they could also act as regulatory enzymes with wide substrate specificity to modify the behavior of cells. In the future, we will try to elucidate the importance of MT-MMPs in blood vessel pathology by expressing MT-MMPs in injured blood vessels. 
